Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
Clinical trial NCT00071955 · COMPLETED
Trial details
- NCT number
- NCT00071955
- Sponsor
- Genitope Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.